Société Brainstorm Cell Therapeutics Inc.
Actions
BCLI
US10501E2019
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,5647 USD | -5,91 % | +17,65 % | +106,85 % |
Métier
Nombre d'employés: 42
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/07 |
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 01/06/20 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/12 |
Chief Tech/Sci/R&D Officer | - | 12/05/22 | |
Kim Thacker
CTO | Chief Tech/Sci/R&D Officer | - | 08/11/21 |
Chief Tech/Sci/R&D Officer | - | 08/11/21 | |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/07 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
General Counsel | - | 12/05/22 | |
Bob Dagher
PRN | Corporate Officer/Principal | 55 | 17/07/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/09/00 |
June Almenoff
BRD | Director/Board Member | 67 | 26/02/17 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
Jacob Frenkel
CHM | Chairman | 81 | 30/03/20 |
Director/Board Member | 63 | 28/10/21 | |
Director/Board Member | 61 | 05/02/18 | |
Nir Naor
BRD | Director/Board Member | 50 | 20/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 48 981 588 | 40 232 111 ( 82,14 %) | 0 | 82,14 % |
Coordonnées société
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+106,85 % | 27,66 M | |
+9,30 % | 46,03 Md | |
+52,73 % | 44,55 Md | |
+7,15 % | 40,8 Md | |
-8,78 % | 28,25 Md | |
+18,68 % | 27,71 Md | |
-21,92 % | 18,82 Md | |
+14,62 % | 13,91 Md | |
+31,85 % | 12,43 Md | |
+4,47 % | 10,81 Md |
- Bourse
- Actions
- Action Brainstorm Cell Therapeutics Inc. - Nasdaq
- Société Brainstorm Cell Therapeutics Inc.